Sol-Gel Technologies Price to Book Ratio 2016-2024 | SLGL

Historical price to book ratio values for Sol-Gel Technologies (SLGL) over the last 10 years. The current price to book ratio for Sol-Gel Technologies as of November 22, 2024 is 0.43.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Sol-Gel Technologies Price/Book Ratio Historical Data
Date Stock Price Book Value per Share Price to Book Ratio
2024-11-21 0.48 0.38
2024-06-30 0.89 $1.25 0.71
2024-03-31 0.98 $1.17 0.84
2023-12-31 1.11 $1.39 0.80
2023-09-30 1.63 $1.55 1.05
2023-06-30 2.99 $1.74 1.72
2023-03-31 3.88 $1.71 2.26
2022-12-31 4.56 $1.83 2.50
2022-09-30 5.02 $2.05 2.45
2022-06-30 4.10 $2.18 1.88
2022-03-31 7.38 $2.17 3.41
2021-12-31 7.40 $2.40 3.08
2021-09-30 10.00 $1.79 5.58
2021-06-30 12.38 $1.70 7.26
2021-03-31 12.38 $2.04 6.06
2020-12-31 9.79 $2.21 4.43
2020-09-30 7.24 $2.49 2.91
2020-06-30 8.95 $2.85 3.14
2020-03-31 7.06 $2.98 2.37
2019-12-31 17.15 $2.57 6.67
2019-09-30 8.99 $2.87 3.13
2019-06-30 9.11 $2.89 3.15
2019-03-31 6.77 $3.11 2.18
2018-06-30 7.72 $4.30 1.79
2018-03-31 10.30 0.00
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.015B $0.002B
Sol-Gel Technologies Ltd.is a clinical-stage dermatology company. It focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. Its product candidates include VERED for the treatment of papulopustular rosacea, TWIN and SIRS-T for the treatment of acne vulgaris, which are in its clinical stage. Sol-Gel Technologies Ltd.is based in Israel.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $19.395B 6.36
Dr Reddy's Laboratories (RDY) India $11.853B 22.68
BridgeBio Pharma (BBIO) United States $4.426B 0.00
Bausch Health Cos (BHC) Canada $2.931B 2.13
Amphastar Pharmaceuticals (AMPH) United States $2.186B 13.14
Supernus Pharmaceuticals (SUPN) United States $2.000B 27.23
Taysha Gene Therapies (TSHA) United States $0.506B 35.29
Personalis (PSNL) United States $0.245B 0.00
Assembly Biosciences (ASMB) United States $0.096B 0.00
Evoke Pharma (EVOK) United States $0.006B 0.00
Teligent (TLGT) United States $0.000B 0.00